Sangamo Therapeutics, Inc. Gains 39.55%
Wed, Jul 24, 2024 at 07:09 PM
Sangamo Therapeutics, Inc. (SGMO:NASDAQ) rocketted at $0.56, a gain of 39.5%. On Wed, Jul 24, 2024, SGMO:NASDAQ touched a New 2-Week High of $0.56. The stock got featured on our News Catalysts scanner on Wed, Jul 24, 2024 at 08:00 AM in the 'BIOTECH' category. From Wed, Jul 10, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Jul 24, 2024 at $0.9 with a volume of 262M+.
About Sangamo Therapeutics, Inc. (SGMO:NASDAQ)
Sangamo Therapeutics Inc is a clinical stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy.
Top 10 Gainers:
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 105.38%
- Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ), 89.55%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Selina Hospitality PLC (SLNA:NASDAQ), 75.77%
- QXO Inc Com Par Value $0.00001 (New) (QXO:NASDAQ), 56.32%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- Sangamo Therapeutics, Inc. (SGMO:NASDAQ), 39.55%
- SCWorx Corp. (WORX:NASDAQ), 39.13%
- KORE Group Holdings Inc. (KORE:NYSE), 33.48%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 31.77%